Us Bancorp \De\ Bristol Myers Squibb CO Transaction History

Us Bancorp \De\

$73 Billion
Q2 2024

A detailed history of Us Bancorp \De\ transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Us Bancorp \De\ holds 2,070,339 shares of BMY stock, worth $110 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,070,339

Previous 2,367,660 12.56%

Holding current value

$110 Million

Previous $128 Million 33.04%

% of portfolio

0.12%

Previous 0.18%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$40.25 - $52.99 $12 Million - $15.8 Million	-297,321 Reduced 12.56%	2,070,339 $86 Million
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $5.77 Million - $6.54 Million	-120,242 Reduced 4.83%	2,367,660 $128 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $9.28 Million - $11.1 Million	-191,438 Reduced 7.14%	2,487,902 $128 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $4.26 Million - $4.77 Million	-73,644 Reduced 2.68%	2,679,340 $156 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $4.98 Million - $5.53 Million	-78,158 Reduced 2.76%	2,752,984 $176 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $5.67 Million - $6.44 Million	-86,342 Reduced 2.96%	2,831,142 $196 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $41.9 Million - $49.6 Million	611,914 Added 26.54%	2,917,484 $210 Million
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $10,865 - $6.42 Million	-83,581 Reduced 3.5%	2,305,570 $164 Million
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $3.61 Million - $3.98 Million	-49,779 Reduced 2.04%	2,389,151 $184 Million
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $2.85 Million - $3.42 Million	-46,333 Reduced 1.86%	2,438,930 $178 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $2.73 Million - $3.19 Million	-50,996 Reduced 2.01%	2,485,263 $155 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $1.98 Million - $2.32 Million	-33,418 Reduced 1.3%	2,536,259 $150 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $334,995 - $364,809	-5,411 Reduced 0.21%	2,569,677 $172 Million
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $998,810 - $1.12 Million	-16,832 Reduced 0.65%	2,575,088 $163 Million
Q4 2020 Feb 04, 2021	SELL	$57.74 - $65.43 $2.16 Million - $2.45 Million	-37,466 Reduced 1.42%	2,591,920 $161 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $1.72 Million - $1.9 Million	-29,898 Reduced 1.12%	2,629,386 $159 Million
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $1.42 Million - $1.66 Million	-25,891 Reduced 0.96%	2,659,284 $156 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $3.94 Million - $5.73 Million	-84,954 Reduced 3.07%	2,685,175 $150 Million
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $29.3 Million - $38.2 Million	594,575 Added 27.33%	2,770,129 $178 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $51,666 - $61,257	-1,208 Reduced 0.06%	2,175,554 $110 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $741,584 - $820,030	16,620 Added 0.77%	2,176,762 $98.7 Million
Q1 2019 May 08, 2019	SELL	$45.12 - $53.8 $36,096 - $43,040	-800 Reduced 0.04%	2,160,142 $103 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $1.53 Million - $1.98 Million	-31,368 Reduced 1.43%	2,160,942 $112 Million
Q3 2018 Nov 01, 2018	SELL	$55.19 - $62.25 $1.66 Million - $1.88 Million	-30,125 Reduced 1.36%	2,192,310 $136 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $1.95 Million - $2.43 Million	-38,580 Reduced 1.71%	2,222,435 $123 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $2.07 Million - $2.39 Million	34,576 Added 1.55%	2,261,015 $143 Million
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $1.23 Million - $1.34 Million	-20,446 Reduced 0.91%	2,226,439 $136 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $124 Million - $143 Million	2,246,885	2,246,885 $143 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account